Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$145,792
in 2 filings, $146K under 10b5-1 plans

Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-29 PAPA JOSEPH C President and CEO Grant or award +187,708 493,153
2026-03-05 PAPA JOSEPH C President and CEO Shares withheld for taxes −37,055 $8.44 $313K 305,445
2026-03-03 PAPA JOSEPH C President and CEO Grant or award · Employee Stock Option (Right to buy) +252,194 1,784,694
2025-05-13 PAPA JOSEPH C President and CEO Purchase +60,000 $5.83 $350K 342,500
2025-03-12 PAPA JOSEPH C President and CEO Grant or award · Employee Stock Options (Right to Buy) +250,000 1,282,500
2025-03-12 PAPA JOSEPH C President and CEO Grant or award · Employee Stock Options (Right to Buy) +250,000 1,532,500
2025-03-06 PAPA JOSEPH C President and CEO Grant or award +282,500 282,500
2025-03-06 PAPA JOSEPH C President and CEO Grant or award · Employee Stock Options (Right to Buy) +282,500 1,032,500
2024-03-13 PAPA JOSEPH C President and CEO Grant or award · Employee Stock Options (Right to Buy) +750,000 750,000

Page 1 of 1 · 9 trades